{"product_id":"pharmaceutical-biopharmaceutical-contract-manufacturing-market-global-industry-size-share-trends-opportunity-and-forecast-2018-2028","title":"Pharmaceutical \u0026 Biopharmaceutical Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028","description":"\u003cp\u003ePharmaceutical \u0026amp; Biopharmaceutical Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028\u003c\/p\u003e\n\n\u003cp\u003eGlobal pharmaceutical \u0026amp; biopharmaceutical contract manufacturing market is expected to register significant growth during the forecast period, 2024-2028. The increasing focus on contract manufacturing companies in expanding their capabilities to manufacture biological drugs, along with establishing new services to meet the growing demand of biopharmaceutical companies, which is expected to bolster the growth of the market. Further, the increasing investment in advanced manufacturing technologies by Contract Development \u0026amp; Manufacturing Organizations (CDMOs) is a major factor, which is anticipated to drive the market growth in coming years. Also, increasing drug development and manufacturing activities by pharmaceutical companies is propelling the growth of global pharmaceutical \u0026amp; biopharmaceutical contract manufacturing market. For instance, in 2022, INCOG BioPharma Services, the Indiana-based contract development and manufacturing organization (CDMO) which specialize in sterile injectables, unveiled that the construction of its manufacturing facility and global headquarters in Fishers, is almost completed.\u003c\/p\u003e\n\n\u003cp\u003eContract manufacturing is a form of outsourcing where a manufacturing company enters into an agreement with another manufacturing firm to develop innovative products and services.\u003c\/p\u003e \n\n\u003cp\u003eGlobal pharmaceutical \u0026amp; biopharmaceutical contract manufacturing market is segmented into sector, product type, service, drug type, company, and region. Based on service type, the market is segmented into pharmaceutical manufacturing services, biologics manufacturing services and drug development services. The pharmaceutical manufacturing services is further segmented into pharmaceutical API manufacturing services and pharmaceutical FDF manufacturing services. Similarly, the biologics manufacturing services is segmented into biologic FDF manufacturing services and biologics API manufacturing services. Among these, the pharmaceutical manufacturing services holds largest market share and is expected to witness fastest growth during the forecast period. This is attributed to the increasing number of sterile formulations and intensive drug development activities.\u003c\/p\u003e \n\n\u003cp\u003eBased on region, Asia Pacific is expected to register fastest growth during the forecast period owing to improving healthcare infrastructure and availability of highly skilled workforce. Many pharmaceutical companies are setting up their manufacturing units in countries such as China and India, due to low manufacturing and operational costs. Therefore, making Asian countries hub for outsourcing.\u003c\/p\u003e \n\n\u003cp\u003eMajor companies operating in global pharmaceutical \u0026amp; biopharmaceutical contract manufacturing market include Jubilant Pharmova Limited, JRS PHARMA GmbH \u0026amp; Co, Boehringer Ingelheim GmbH, Lonza Group, Rentschler Biotechnologie GmbH, Inno Biologics Sdn Bhd, INCOG BioPharma Services, Baxter Biopharma Solutions, Catalent Pharma Solutions, and Kemwell Biopharma Private Limited. Leading companies are continuously carrying out research and development activities to bring new medicines. Also, favourable regulations by government in regions such as Asia Pacific is enabling manufacturers to expand their businesses efficiently.\u003c\/p\u003e \n\n\u003cp\u003eObjective of the Study: To analyze and forecast the market size of global pharmaceutical \u0026amp; biopharmaceutical contract manufacturing market.To forecast global pharmaceutical \u0026amp; biopharmaceutical contract manufacturing market based on sector, product type, service, drug type and regional distribution.To identify drivers and challenges for global pharmaceutical \u0026amp; biopharmaceutical contract manufacturing market. To examine competitive developments such as expansions, new product launches, mergers \u0026amp; acquisitions etc. in global pharmaceutical \u0026amp; biopharmaceutical contract manufacturing market.To identify and analyze the profile of leading players operating in the global pharmaceutical \u0026amp; biopharmaceutical contract manufacturing market.TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of pharmaceutical \u0026amp; biopharmaceutical manufacturing companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research.\u003c\/p\u003e \n\n\u003cp\u003eTechSci Research calculated global pharmaceutical \u0026amp; biopharmaceutical contract manufacturing market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analysing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.\u003c\/p\u003e\n\n\u003cp\u003eKey Target Audience:Pharmaceutical \u0026amp; biopharmaceutical manufacturers\/companies and other stakeholdersGovernment bodies such as regulating authorities and policy makersOrganizations, industry associations, forums and alliances related to pharmaceutical \u0026amp; biopharmaceutical contract manufacturing Market research and consulting firmsThe study is useful in providing answers to several critical questions that are important for the industry stakeholders such as pharmaceutical \u0026amp; biopharmaceutical contract manufacturing companies, partners, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.\u003c\/p\u003e \n\n\u003cp\u003eReport Scope:\u003c\/p\u003e\n\n\u003cp\u003eIn this report, global pharmaceutical \u0026amp; biopharmaceutical contract manufacturing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:Global Pharmaceutical \u0026amp; Biopharmaceutical Contract Manufacturing Market, By Sector:PharmaceuticalBiopharmaceuticalGlobal Pharmaceutical \u0026amp; Biopharmaceutical Contract Manufacturing Market, By Product Type:Active Pharmaceutical Ingredients (API)Finished Dosage FormulationTabletCapsuleOral LiquidsParenteral\/InjectablesOthersAdvanced Drug Delivery ProductsOver the Counter (OTC) MedicinesNutritional ProductsOthersGlobal Pharmaceutical \u0026amp; Biopharmaceutical Contract Manufacturing Market, By Service:Pharmaceutical Manufacturing ServicesPharmaceutical API Manufacturing ServicesPharmaceutical FDF Manufacturing ServicesBiologics Manufacturing ServicesBiologics FDF Manufacturing ServicesBiologics API Manufacturing ServicesDrug Development ServicesGlobal Pharmaceutical \u0026amp; Biopharmaceutical Contract Manufacturing Market, By Drug Type:Originator \/ PatentedGenericsBiosimilarGlobal Pharmaceutical \u0026amp; Biopharmaceutical Contract Manufacturing Market, By Region:Asia-PacificChinaJapanIndia  South KoreaAustraliaEurope FranceGermanyUnited KingdomItalySpainNorth AmericaUnited StatesMexicoCanadaSouth AmericaBrazilArgentinaColombiaMiddle East \u0026amp; AfricaUAESouth AfricaSaudi ArabiaCompetitive Landscape\u003c\/p\u003e\n\n\u003cp\u003eCompany Profiles: Detailed analysis of the major companies present in global pharmaceutical \u0026amp; biopharmaceutical contract manufacturing market.\u003c\/p\u003e\n\n\u003cp\u003eCompany InformationDetailed analysis and profiling of additional market players (up to five).Profit Margin AnalysisProfit margin analysis in case of direct and indirect sales channel.Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"December, 2022 \/ 112 Pages \/ MCW16225199","offer_id":47639644242226,"sku":null,"price":5880.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/pharmaceutical-biopharmaceutical-contract-manufacturing-market-global-industry-size-share-trends-opportunity-and-forecast-2018-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}